Beyonce's former trainer Craig Adams 'dies due to coronavirus'

So-called ‘breakthrough’ COVID-19 cases occur when people contract the disease 14 days or more after receiving their second dose of the Pfizer-BioNTech or Moderna vaccine or the Johnson & Johnson one-shot jab.

Clinical trials have shown that Pfizer-BioNTech’s vaccine is 95% effective in preventing symptomatic disease and the Moderna vaccine is 94.5% effective.

Meanwhile, real-world data showed the Pfizer jab is 91% effective against all disease for at least six months and the Moderna vaccine is 90% effective.

This means that fully vaccinated people are between 90% and 95% less likely to develop COVID-19 than unvaccinated people.

In addition, Johnson & Johnson’s vaccine trials showed 72% efficacy in the U.S., meaning those who got the one-shot jab are 72% less likely to contract the disease.

When comparing fully vaccinated people who did and did not get sick, the risk is even lower.

The most recent Centers for Disease Control and Prevention (CDC) data show that 10,262 of at least 133 million Americans who have been fully vaccinated against COVID-19 later contracted the disease.

This translates to 0.00716% of people who have completed their vaccine series have gone on to test positive.

It also represents the true odds of getting COVID-19 after full vaccination: less than 0.01%.

What’s more, fully vaccinated people who test positive have mild illnesses, and are very unlikely to be hospitalized or die.

The CDC states that 99.5% of all deaths occur in unvaccinated people.

That means, if the figure applies to the 3,165 Americans who’ve died in July 2021 so far – as of July 13 – about 3,150 deaths would be among unvaccinated people and 15 deaths among fully vaccinated people.